Refurbished medical equipment market seen reaching $30.9 billion by 2033

Persistence Market Research says the global refurbished medical equipment market will grow from $18.8 billion in 2026 to $30.9 billion by 2033, driven by hospital cost pressure, rising diagnostic demand and wider acceptance of certified pre-owned systems. North America remains the largest regional base, while Asia Pacific and Europe offer longer-term growth tied to expansion and sustainability goals.

Why it matters: - Healthcare providers are under pressure to add diagnostic and treatment capacity without taking on the full cost of new equipment. - Refurbished systems can lower capital spending while still giving hospitals, diagnostic centers and specialty clinics access to advanced technology. - Sustainability goals are also pushing the market toward reuse, refurbishment and longer equipment lifecycles.

What happened: - Persistence Market Research estimated the global refurbished medical equipment market at $18.8 billion in 2026. - The firm projects the market will reach $30.9 billion by 2033. - That outlook implies a 5.6% compound annual growth rate from 2026 to 2033. - The report highlights diagnostic imaging equipment as a leading product category.

The details: - Demand is being supported by growing healthcare infrastructure, higher diagnostic workloads and stronger acceptance of professionally restored devices. - Hospitals, diagnostic centers, specialty clinics and other healthcare facilities are key buyers. - Diagnostic imaging systems such as MRI, CT, ultrasound, mammography, X-ray and nuclear imaging are a major refurbishment segment because of their high acquisition costs. - End-user demand also comes from ambulatory facilities and other healthcare organizations. - Hospitals remain a leading customer group because they manage large equipment portfolios and often have to balance modernization with budget limits. - Smaller facilities are turning to refurbished systems to improve clinical capabilities without buying new equipment. - North America is expected to remain a prominent regional market because of established refurbishment networks, a large installed equipment base and broad acceptance of certified pre-owned systems. - Asia Pacific offers long-term upside as healthcare infrastructure expands and diagnostic capacity increases. - Europe is seeing demand supported by circular-economy principles, reuse strategies, sustainability goals and structured refurbishment practices. - Prominent market participants include GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, Block Imaging, Soma Technology, Avante Health Solutions, Integrity Medical Systems, EverX and Atlantis Worldwide. - Competition is centered on equipment quality, certification, warranties, technical expertise, inventory availability, installation and after-sales service. - The report includes a free sample, customization options and the full report.

Between the lines: - OEM-certified refurbishment is becoming more important because standardized inspection, testing, servicing and quality control improve buyer confidence. - Lifecycle economics are shaping purchasing decisions as healthcare providers compare warranties, service coverage, software compatibility and operating performance. - Quality concerns, remaining operational life, maintenance history, parts availability and regulatory differences can still slow adoption. - Transportation, installation, calibration, training and service access can add to total ownership costs, especially for imaging systems.

What's next: - Emerging healthcare markets are likely to keep attracting suppliers that can offer reliable equipment plus warranties, maintenance and technical support. - Manufacturers and refurbishment specialists are expected to expand take-back, trade-in, remanufacturing, parts recovery and lifecycle management programs. - Buyers will keep weighing refurbished systems against new purchases based on cost, compliance, service and long-term performance.

The bottom line: - Refurbished medical equipment is moving from a budget alternative to a mainstream procurement option as providers seek lower-cost access to advanced technology.